Roche Collaborates with Aileron to Develop Stapled Peptide Therapeutics |
Abstract
|
Heather Cartwright |
|
Novartis Acquires Option to Phase II siRNA Drug from Quark Pharmaceuticals |
Abstract
|
Heather Cartwright |
|
Onyx Pharmaceuticals Out-Licenses Japanese Rights to Proteasome Inhibitors |
Abstract
|
Heather Cartwright |
|
Shire Licenses Rights to Duchenne Muscular Dystrophy Drug Candidate from Acceleron |
Abstract
|
Heather Cartwright |
|
Abbott Pays Top Dollar to License Phase II Chronic Kidney Disease Therapy from Reata Pharmaceuticals |
Abstract
|
Heather Cartwright |
|
Johnson & Johnson Plans to Enter Vaccines Market via Crucell Acquisition |
Abstract
|
Heather Cartwright |
|
Pfizer Acquires FoldRx to Broaden its Orphan Drug Portfolio |
Abstract
|
Heather Cartwright |
|
Endo to Acquire Qualitest and Expand its Generics Portfolio |
Abstract
|
Heather Cartwright |
|
Sun Pharma Finally Acquires Controlling Stake in Taro |
Abstract
|
Heather Cartwright |
|
Roche Strengthens CNS Pipeline with reMYND Alliance |
Abstract
|
Heather Cartwright |
|
Orexigen Finds Partner for Obesity Drug Prior to Regulatory Approval Decision |
Abstract
|
Heather Cartwright |
|